ロード中...

Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia

The production of an L1 metallo-β-lactamase and an L2 serine active-site β-lactamase precludes the use of β-lactams for the treatment of Stenotrophomonas maltophilia infections. Preclinical data suggest that cefiderocol is the first approved β-lactam with reliable activity against S. maltophilia, bu...

詳細記述

保存先:
書誌詳細
出版年:Antimicrob Agents Chemother
主要な著者: Biagi, M., Vialichka, A., Jurkovic, M., Wu, T., Shajee, A., Lee, M., Patel, S., Mendes, R. E., Wenzler, E.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449157/
https://ncbi.nlm.nih.gov/pubmed/32571820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00559-20
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!